💥 Recurrence was associated with post-treatment ctDNA positivity in locally advanced HNSCC according to data from a phase 2 trial, providing crucial information to trial investigators.

Read more here ➡️: https://t.co/ICVOZeb2eo

#hncsm #oncology #AACR26 @AACR